Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | E2F5 |
| Upstream (Parents) |
|---|
| (<<) TFAP2B → E2F5 |
| (<<) FOXM1 → E2F5 |
| (<<) ARNTL2 → E2F5 |
| (<<) ETV1 → E2F5 |
| (<<) TAF4B → E2F5 |
| (<<) MYC → E2F5 |
| (<<) AEBP1 → E2F5 |
| (<<) RUNX1T1 → E2F5 |
| (<<) PCGF2 → E2F5 |
| (<<) HOXC9 → E2F5 |
| (<<) TCF4 → E2F5 |
| (<<) RARA → E2F5 |
| (<<) TSHZ3 → E2F5 |
| (<<) ZFHX3 → E2F5 |
| (<<) EPAS1 → E2F5 |
| (<<) KLF9 → E2F5 |
| (<<) TGIF2 → E2F5 |
| (<<) MYBL2 → E2F5 |
| (<<) NFKB2 → E2F5 |
| (<<) RUNX1 → E2F5 |
| (<<) FOXO1 → E2F5 |
| (<<) NR2C2 → E2F5 |
| Downstream (Children) |
|---|
| E2F5 → TP63 (>>) |
| E2F5 → ZIC2 (>>) |
| E2F5 → HOXA5 (>>) |
| E2F5 → THRB (>>) |
| E2F5 → SCML1 (>>) |
| E2F5 → CREM (>>) |
| E2F5 → HOXA7 (>>) |
| E2F5 → EN2 (>>) |
| E2F5 → RFX5 (>>) |
| E2F5 → AHCTF1 (>>) |
| E2F5 → PHTF1 (>>) |
| E2F5 → NOLC1 (>>) |
| E2F5 → NFIC (>>) |
